|
ASF1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.643300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.119000E-03 |
| Normal-vs-Stage2 |
1.375610E-01 |
| Normal-vs-Stage3 |
1.567600E-04 |
| Normal-vs-Stage4 |
2.42399999994536E-06 |
| Stage1-vs-Stage2 |
6.427400E-01 |
| Stage1-vs-Stage3 |
2.451900E-02 |
| Stage1-vs-Stage4 |
5.960100E-03 |
| Stage2-vs-Stage3 |
5.786000E-02 |
| Stage2-vs-Stage4 |
1.025730E-02 |
| Stage3-vs-Stage4 |
3.478000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.988800E-04 |
| Normal-vs-AfricanAmerican |
3.412200E-02 |
| Normal-vs-Asian |
2.896200E-02 |
| Caucasian-vs-AfricanAmerican |
9.033400E-01 |
| Caucasian-vs-Asian |
4.297000E-01 |
| AfricanAmerican-vs-Asian |
6.857400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.107790E-02 |
| Normal-vs-Female |
1.239470E-03 |
| Male-vs-Female |
3.997800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.735600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.242500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.918800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.565700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.600010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.056800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.480000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.215200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.367200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.327200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.418300E-03 |
| Classical-VS-Follicular |
5.856000E-02 |
| Classical-VS-Other |
5.831000E-01 |
| Classical-VS-Normal |
3.282200E-03 |
| Tall-VS-Follicular |
8.47370000000014E-05 |
| Tall-VS-Other |
3.116300E-02 |
| Tall-VS-Normal |
1.69539999994583E-06 |
| Follicular-VS-Other |
8.763400E-01 |
| Follicular-VS-Normal |
3.359400E-01 |
| Other-VS-Normal |
4.808200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.981500E-03 |
| Normal-vs-N1 |
3.86439999999766E-05 |
| N0-vs-N1 |
2.431700E-02 |
|
|
